Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Novocure (NVCR) Tops Q4 EPS by 2c, Revenues Beat
February 27, 2020 6:16 AM ESTNovocure (NASDAQ: NVCR) reported Q4 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $99.2 million versus the consensus estimate of $97.91 million.
We start 2020 with substantial momentum from an exceptional 2019, said Asaf Danziger, Novocures Chief Executive Officer, In 2019, we generated $351 million in net revenues and added... More



